1. Home
  2. RYAN vs GRFS Comparison

RYAN vs GRFS Comparison

Compare RYAN & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryan Specialty Holdings Inc.

RYAN

Ryan Specialty Holdings Inc.

HOLD

Current Price

$58.27

Market Cap

7.3B

Sector

Finance

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.82

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYAN
GRFS
Founded
2010
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
5.9B
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
RYAN
GRFS
Price
$58.27
$8.82
Analyst Decision
Buy
Hold
Analyst Count
14
1
Target Price
$67.50
$10.30
AVG Volume (30 Days)
1.5M
751.4K
Earning Date
10-30-2025
01-01-0001
Dividend Yield
0.83%
1.61%
EPS Growth
N/A
N/A
EPS
N/A
0.64
Revenue
$2,905,944,000.00
$8,821,017,248.00
Revenue This Year
$27.58
$5.31
Revenue Next Year
$16.69
$6.02
P/E Ratio
$217.26
$16.99
Revenue Growth
24.99
7.31
52 Week Low
$50.08
$6.19
52 Week High
$77.16
$11.14

Technical Indicators

Market Signals
Indicator
RYAN
GRFS
Relative Strength Index (RSI) 59.95 49.11
Support Level $55.54 $8.33
Resistance Level $57.84 $8.64
Average True Range (ATR) 1.40 0.21
MACD 0.14 0.06
Stochastic Oscillator 81.45 82.64

Price Performance

Historical Comparison
RYAN
GRFS

About RYAN Ryan Specialty Holdings Inc.

Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: